Autologous Platelet-Rich Fibrin in the Treatment of Refractory Macular Holes.
Case Rep Ophthalmol Med 2019;
2019:6054215. [PMID:
31781448 PMCID:
PMC6875262 DOI:
10.1155/2019/6054215]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2019] [Accepted: 09/05/2019] [Indexed: 11/17/2022] Open
Abstract
Purpose
To describe a novel method for the treatment of refractory macular holes.
Methods
Two case reports on the use of autologous platelet rich fibrin (PRF), followed by sulfur hexafluoride gas tamponade to facilitate closure of refractory macular holes.
Results
Macular holes were succesfully closed within a week in both cases. Best corrected Snellen visual acuities improved from counting fingers to 0.16 in the first case, and from 0.05 to 0.2 in the second case. No complication occurred during or after the procedures.
Conclusion
The use of autologous PRF seems to be a safe and effective alternative method for the treatment of refractory macular holes. Further experience and studies are required to assess the value of autologous PRF in the management of challenging macular hole cases of different etiologies. To the best of our knowledge, this is the first use of autologous PRF in the treatment of macular holes.
Collapse